12 results match your criteria: "Hospital Annecy-Genevois[Affiliation]"

Circumflex distortion following mitral valve repair.

Catheter Cardiovasc Interv

November 2024

Cardiology Department, Hospital Annecy-Genevois, Epagny Metz-Tessy, France.

Mitral valve repair or replacement poses a potential risk of injury to the left circumflex coronary artery (LCx). Such injuries can arise from either direct LCx injury caused by encircling or transfixing stitches, or indirect occlusion resulting from the distortion of adjacent tissues. We provide and illustrate a representative image depicting LCx distortion.

View Article and Find Full Text PDF

Association Between Aortic Wall Thrombus and Thromboembolic Events After Transfemoral Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv

July 2024

Cardiology Department, (Institut de Cardiologie) Hospital Croix-Rousse and Hospital Lyon Sud, Hospices Civils de Lyon, Lyon, France; University of Lyon, CREATIS UMR5220, INSERM U1044, INSA-15, Lyon, France. Electronic address:

Background: Thromboembolic events, particularly strokes, remain a major complication of transcatheter aortic valve replacement (TAVR). Embolic protection devices have failed to show significant clinical benefit in large randomized clinical trials. Aortic wall thrombus (AWT) is often observed on multidetector computed tomography during TAVR work-up, but its prognostic significance is uncertain.

View Article and Find Full Text PDF

French national protocol for the management of congenital ichthyosis.

Ann Dermatol Venereol

March 2024

University Hospital Center of Toulouse, Reference Centre for Rare Skin Diseases, Department of Dermatology, Larrey Hospital, 24, Chemin de Pouvourville, TSA 30030 Toulouse Cedex 9, France. Electronic address:

Article Synopsis
  • * CI significantly affects quality of life and typically requires ongoing treatment, as there is currently no cure, only options for managing symptoms.
  • * The management protocol for CI, developed in line with 2012 guidelines from the French National Authority for Health, aims to provide clinicians with evidence-based recommendations for treating these rare conditions.
View Article and Find Full Text PDF

Purpose: We assessed the multi-institutional safety of same day discharge for robot-assisted radical prostatectomy within a single health care system.

Materials And Methods: We included 358 patients undergoing planned same day discharge for robot-assisted radical prostatectomy at 6 French centers. Primary outcomes were same day discharge failure, and 30-day complication and readmission rates.

View Article and Find Full Text PDF

Importance: The association between total prehospital time and mortality in physician-staffed trauma systems remains uncertain.

Objective: To describe the association of total prehospital time and in-hospital mortality in prehospital, physician-staffed trauma systems in France, with the hypothesis that total prehospital time is associated with increased mortality.

Design, Setting, And Participants: This cohort study was conducted from January 2009 to December 2016.

View Article and Find Full Text PDF

Objective: To develop and validate a prognostic model and a simple model to predict death due to bleeding in trauma patients.

Design: Cross-sectional study with multivariable logistic regression using data from two large trauma cohorts.

Setting: 274 hospitals from 40 countries in the Clinical Randomisation of Anti-fibrinolytic in Significant Haemorrhage (CRASH-2) trial and 24 hospitals in the Northern French Alps Trauma registry.

View Article and Find Full Text PDF

Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.

Am J Hematol

June 2019

Department of Vascular Medicine, CNRS / TIMC-IMAG UMR 5525/Themas and F-CRIN InnoVTE Network, Grenoble, Auvergne-Rhône-Alpes, France.

The risk of venous thromboembolism (VTE) is higher in myeloma patients receiving immunomodulatory compounds. A VTE prophylaxis using low-molecular-weight heparin or aspirin is therefore proposed. Apixaban is an oral direct anti-Xa.

View Article and Find Full Text PDF

Objectives: To assess the reduction of transfusions rate in transfusion-dependent patients with low-risk myelodysplastic syndrome (MDS) with iron overload treated with deferasirox.

Methods: Prospective observational study. Primary endpoint was reduction in transfusion requirements (RTR) at 3 months, (assessed on 8-week period).

View Article and Find Full Text PDF

A 72-year-old man was referred to our catheterization laboratory 48 hours after a non-ST-segment elevation myocardial infarction. His medical history included coronary artery disease (CAD) (percutaneous coronary intervention of the right coronary artery and chronic total occlusion of the circumflex artery), atrial fibrillation (AF), and chronic kidney disease. An electrocardiogram showed a pre-existent left bundle-branch block and the patient's maximum cardiac troponin concentration was 8.

View Article and Find Full Text PDF